These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29686981)

  • 1. Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
    Gupta S; Palmer C; Bik EM; Cardenas JP; Nuñez H; Kraal L; Bird SW; Bowers J; Smith A; Walton NA; Goddard AD; Almonacid DE; Zneimer S; Richman J; Apte ZS
    Front Public Health; 2018; 6():77. PubMed ID: 29686981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.
    Haguenoer K; Giraudeau B; Gaudy-Graffin C; de Pinieux I; Dubois F; Trignol-Viguier N; Viguier J; Marret H; Goudeau A
    Gynecol Oncol; 2014 Aug; 134(2):302-8. PubMed ID: 24905772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review.
    Stewart DE; Gagliardi A; Johnston M; Howlett R; Barata P; Lewis N; Oliver T; Mai V;
    J Obstet Gynaecol Can; 2007 Oct; 29(10):817-28. PubMed ID: 17915065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France.
    Tamalet C; Halfon P; Retraite LL; Grob A; Leandri FX; Heid P; Sancho-Garnier H; Piana L
    J Clin Virol; 2016 May; 78():102-7. PubMed ID: 27015435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of self-sampling for HPV testing in Africa.
    Nodjikouambaye ZA; Adawaye C; Mboumba Bouassa RS; Sadjoli D; Bélec L
    Int J Gynaecol Obstet; 2020 May; 149(2):123-129. PubMed ID: 32037532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.
    Dzuba IG; Díaz EY; Allen B; Leonard YF; Lazcano Ponce EC; Shah KV; Bishai D; Lorincz A; Ferris D; Turnbull B; Hernández Avila M; Salmerón J
    J Womens Health Gend Based Med; 2002 Apr; 11(3):265-75. PubMed ID: 11988136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening.
    Hwang SH; Shin HY; Lee DO; Sung NY; Lee B; Lee DH; Jun JK
    Sci Rep; 2018 Jun; 8(1):9015. PubMed ID: 29899531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
    Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
    Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
    Madzima TR; Vahabi M; Lofters A
    Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.